Evidence map›Paper›PMID 29344837›Full record

ArticleNeurotoxicity research2018

Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)

C Ceresa, G Nicolini, S Semperboni, V Gandin, M Monfrini, F Avezza, P Alberti, A Bravin, M Pellei, C Santini and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)-a white paper.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

C CeresaExperimental Neurology Unit and Milan Center for Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore, 48, 20900, Monza, MB, Italy.
G NicoliniExperimental Neurology Unit and Milan Center for Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore, 48, 20900, Monza, MB, Italy.
S SemperboniExperimental Neurology Unit and Milan Center for Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore, 48, 20900, Monza, MB, Italy.
V GandinDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
M MonfriniExperimental Neurology Unit and Milan Center for Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore, 48, 20900, Monza, MB, Italy.
F AvezzaExperimental Neurology Unit and Milan Center for Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore, 48, 20900, Monza, MB, Italy.
P AlbertiExperimental Neurology Unit and Milan Center for Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore, 48, 20900, Monza, MB, Italy.
A BravinID17, European Synchrotron Radiation Facility, Grenoble, France.
M PelleiSchool of Science and Technology - Chemistry Division, University of Camerino, Camerino, Italy.
C SantiniSchool of Science and Technology - Chemistry Division, University of Camerino, Camerino, Italy.
Guido CavalettiExperimental Neurology Unit and Milan Center for Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore, 48, 20900, Monza, MB, Italy. guido.cavaletti@unimib.it.
University of Milano-Bicocca · ITUniversità di Camerino · ITEuropean Synchrotron Radiation Facility · FRUniversity of Padua · IT

Funding

Associazione Italiana per la Ricerca sul Cancro IG 2016 Id.18631
6 · The paper itself

Abstract

[Cu(thp)

Indexed as

Action PotentialsAdamantaneAnimalsAntineoplastic AgentsBortezomibCarcinomaCell Line, TumorCells, CulturedCisplatinCopperDose-Response Relationship, DrugEmbryo, MammalianFemaleGanglia, SpinalGoldHumans1,3,5-triaza-7-phosphaadamantaneAdamantaneAntineoplastic AgentsATP dependent 26S proteaseBortezomibCisplatinCopperGoldOrganophosphorus CompoundsProteasome Endopeptidase ComplexTubulinChemotherapyMetal-based drugNeurotoxicityPhosphane complexes

Identifiers

PMID29344837
OpenAlexW2783619582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.